ArticleBMJ open2019

Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial.

Kenichi Yamahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.